NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, acetyl viologen significantly induced apoptosis by regulating ROS accumulation, depleting Bcr-Abl, and blocking the NF-κB signaling pathway, indicating its therapeutic potential for treating chronic myeloid leukemia (CML) patients.